Skip to content

Clinical trials

Phase 4 Psychotic Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 4 Country / region: United States Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
200311
20049
20058
200617
20075
20088
20097
20104
20114
20122
20132
20143
20152
20162
20182
20195
20202
20224
20234
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Recruiting11
Terminated9
Withdrawn5
Unknown status4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
New York State Psychiatric Institute6
University of Massachusetts, Worcester6
Massachusetts General Hospital5
National Institute of Mental Health (NIMH)5
University of California, Los Angeles5
University of Maryland, Baltimore5
Dartmouth-Hitchcock Medical Center4
North Suffolk Mental Health Association4
Northwell Health4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders121
Schizophrenia107
Bipolar Disorder21
Alcoholism8
Psychomotor Agitation8
Substance-Related Disorders8
Major Depressive Disorder6
Obesity6
Mental Disorders5
Cognitive Dysfunction4

Trials

Showing 1 to 25 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.